Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre

Frontiers in Microbiology

Volumn 8, Issue MAY, 2017, Pages

  Gould, Victoria M W ^a   Francis, James N ^b   Anderson, Katie J ^b   Georges, Bertrand ^b   Cope, Alethea V ^a   Tregoning, John S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Human infection challenge study; IgA; Influenza; Nasal; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE PAIN; HEADACHE; HEMAGGLUTINATION INHIBITION; HOARSENESS; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H1N1); NAUSEA AND VOMITING; NOSE CAVITY; OTALGIA; POLYMERASE CHAIN REACTION; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RHINORRHEA; SNEEZING; SORE THROAT; VIRUS SHEDDING;

EID: 85019730875     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00900     Document Type: Article

References (35)

1. Ambrose, C. S., Wu, X., Jones, T., and Mallory, R. M. (2012). The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 30, 6794-6801. doi: 10.1016/j.vaccine.2012.09.018
2. Asahi, Y., Yoshikawa, T., Watanabe, I., Iwasaki, T., Hasegawa, H., Sato, Y., et al. (2002). Protection against influenza virus infection in polymeric ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168, 2930-2938. doi: 10.4049/jimmunol.168.6.2930
3. Barría, M. I., Garrido, J. L., Stein, C., Scher, E., Ge, Y., Engel, S. M., et al. (2013). Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J. Infect. Dis. 207, 115-124. doi: 10.1093/infdis/jis641
4. Belshe, R. B., Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., et al. (2000). Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 181, 1133-1137. doi: 10.1086/315323
5. Bergin, P., Langat, R., Omosa-Manyonyi, G., Farah, B., Ouattara, G., Park, H., et al. (2016). Assessment of anti-HIV-1 antibodies in oral and nasal compartments of volunteers from three different populations. J. Acquir. Immune Defic. Syndr. 73, 130-137. doi: 10.1097/QAI.0000000000001094
6. Black, S., Nicolay, U., Vesikari, T., Knuf, M., Del Giudice, G., Della Cioppa, G., et al. (2011). Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr. Infect. Dis. J. 30, 1081-1085. doi: 10.1097/INF.0b013e3182367662
7. Brown, T. A., Murphy, B. R., Radl, J., Haaijman, J. J., and Mestecky, J. (1985). Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans. J. Clin. Microbiol. 22, 259-264.
8. Carrat, F., Vergu, E., Ferguson, N. M., Lemaitre, M., Cauchemez, S., Leach, S., et al. (2008). Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167, 775-785. doi: 10.1093/aje/kwm375
9. Clements, M. L., Betts, R. F., Tierney, E. L., and Murphy, B. R. (1986). Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24, 157-160.
10. Clements, M. L., and Murphy, B. R. (1986). Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J. Clin. Microbiol. 23, 66-72.
11. Everitt, A. R., Clare, S., Mcdonald, J. U., Kane, L., Harcourt, K., Ahras, M., et al. (2013). Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8:e80723. doi: 10.1371/journal.pone.0080723
12. Everitt, A. R., Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., et al. (2012). IFITM3 restricts the morbidity and mortality associated with influenza. Nature (London) 484, 519-523. doi: 10.1038/nature10921
13. Frise, R., Bradley, K., Van Doremalen, N., Galiano, M., Elderfield, R. A., Stilwell, P., et al. (2016). Contact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistance. Sci. Rep. 6:29793. doi: 10.1038/srep29793
14. Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., et al. (2016). Prevention and control of seasonal influenza with vaccines. MMWR Recomm. Rep. 65, 1-54. doi: 10.15585/mmwr.rr6505a1
15. Habibi, M. S., Jozwik, A., Makris, S., Dunning, J., Paras, A., Devincenzo, J. P., et al. (2015). Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 191, 1040-1049. doi: 10.1164/rccm.201412-2256OC
16. Hobson, D., Curry, R. L., Beare, A. S., and Ward-Gardner, A. (1972). The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70, 767-777. doi: 10.1017/S0022172400022610
17. Lambert, L., Kinnear, E., Mcdonald, J. U., Grodeland, G., Bogen, B., Stubsrud, E., et al. (2016). DNA vaccines encoding antigen targeted to MHC Class II induce influenza-specific CD8+ T cell responses, enabling faster resolution of influenza disease. Front. Immunol. 7:321. doi: 10.3389/fimmu.2016.00321
18. Mastelic Gavillet, B., Eberhardt, C. S., Auderset, F., Castellino, F., Seubert, A., Tregoning, J. S., et al. (2015). MF59 Mediates Its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life. J. Immunol. 194, 4836-4845. doi: 10.4049/jimmunol.1402071
19. Mazanec, M. B., Coudret, C. L., and Fletcher, D. R. (1995). Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J. Virol. 69, 1339-1343.
20. Mbawuike, I. N., Pacheco, S., Acuna, C. L., Switzer, K. C., Zhang, Y., and Harriman, G. R. (1999). Mucosal immunity to influenza without IgA: an IgA knockout mouse model. J. Immunol. 162, 2530-2537.
21. Pillai, P. S., Molony, R. D., Martinod, K., Dong, H., Pang, I. K., Tal, M. C., et al. (2016). Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352, 463-466. doi: 10.1126/science.aaf3926
22. Piralla, A., Daleno, C., Pariani, E., Conaldi, P., Esposito, S., Zanetti, A., et al. (2013). Virtual quantification of influenza A virus load by real-time RT-PCR. J. Clin. Virol. 56, 65-68. doi: 10.1016/j.jcv.2012.09.011
23. Reber, A., and Katz, J. (2013). Immunological assessment of influenza vaccines and immune correlates of protection. Expert Rev. Vaccines 12, 519-536. doi: 10.1586/erv.13.35
24. Renegar, K. B., Small, P. A. Jr., Boykins, L. G., and Wright, P. F. (2004). Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173, 1978-1986. doi: 10.4049/jimmunol.173.3.1978
25. Rossen, R. D., Butler, W. T., Waldman, R. H., Alford, R. H., Hornick, R. B., Togo, Y., et al. (1970). The proteins in nasal secretion. II. A longitudinal study of IgA and neutralizing antibody levels in nasal washings from men infected with influenza virus. JAMA 211, 1157-1161. doi: 10.1001/jama.1970.03170070027005
26. Russell, R. F., Mcdonald, J. U., Ivanova, M., Zhong, Z., Bukreyev, A., and Tregoning, J. S. (2015). Partial attenuation of respiratory syncytial virus with a deletion of a small hydrophobic gene is associated with elevated interleukin-1beta responses. J. Virol. 89, 8974-8981. doi: 10.1128/JVI.01070-15
27. Russell, R. F., Mcdonald, J. U., Lambert, L., and Tregoning, J. S. (2016). Use of the microparticle NanoSiO2 as an adjuvant to boost vaccine immune responses in neonatal mice against influenza. J. Virol. 90, 4735-4744. doi: 10.1128/JVI.03159-15
28. Seibert, C. W., Rahmat, S., Krause, J. C., Eggink, D., Albrecht, R. A., Goff, P. H., et al. (2013). Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J. Virol. 87, 7793-7804. doi: 10.1128/JVI.00979-13
29. Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., et al. (2013). Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305-1312. doi: 10.1038/nm.3350
30. Sridhar, S., Brokstad, K. A., and Cox, R. J. (2015). Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel) 3, 373-389. doi: 10.3390/vaccines3020373
31. Tamura, S., Funato, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C., et al. (1991). Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur. J. Immunol. 21, 1337-1344. doi: 10.1002/eji.1830210602
32. Wagner, D. K., Clements, M. L., Reimer, C. B., Snyder, M., Nelson, D. L., and Murphy, B. R. (1987). Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J. Clin. Microbiol. 25, 559-562.
33. Watson, J. M., Francis, J. N., Mesens, S., Faiman, G. A., Makin, J., Patriarca, P., et al. (2015). Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans. Virol. J. 12, 13. doi: 10.1186/s12985-015-0240-5
34. Wright, P. F., Hoen, A. G., Ilyushina, N. A., Brown, E. P., Ackerman, M. E., Wieland-Alter, W., et al. (2016). Correlates of immunity to influenza as determined by challenge of children with live, attenuated influenza vaccine. Open Forum Infect. Dis. 3:ofw108. doi: 10.1093/ofid/ofw108
35. Wright, P. F., Murphy, B. R., Kervina, M., Lawrence, E. M., Phelan, M. A., and Karzon, D. T. (1983). Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory. Infect. Immun. 40, 1092-1095.